Intec Pharma Ltd. appointed Roger Pomerantz as a director.
Pomerantz's appointment brings the number of Intec's board members to seven, six of whom are independent. Pomerantz is the president, CEO and board chairman of Seres Therapeutics Inc.
Jerusalem, Israel-based Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Accordion Pill is an oral drug delivery system designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism.